Acute Respiratory Distress Syndrome (ARDS) Clinical Presentation and Management

Primary Respiratory Symptoms

The American Thoracic Society recommends that ARDS be characterized by severe dyspnea and unremitting tachypnea that persists despite oxygen supplementation 1
Profound hypoxemia with PaO2/FiO2 ratio ≤300 mmHg for acute lung injury, ≤200 mmHg for moderate ARDS, and ≤100 mmHg for severe ARDS is a key diagnostic criterion 2
Increased work of breathing manifesting as accessory muscle use, paradoxical breathing patterns, and inability to speak in complete sentences is a common symptom 1
Rapidly progressive respiratory symptoms with acute onset within one week of a known insult or new/worsening respiratory symptoms are characteristic of ARDS 2
Elevated minute ventilation requirements to maintain CO2 excretion due to increased dead space ventilation and intrapulmonary shunting are often necessary 1

Bilateral pulmonary opacities that cannot be fully explained by cardiac failure or fluid overload are a key radiographic finding 2
The Society of Critical Care Medicine notes that bilateral pulmonary infiltrates on chest X-ray without evidence of fluid overload are typical of ARDS 1
The infiltrates may appear as bilateral, diffuse, peripheral, interstitial patterns but can also present asymmetrically, patchy, or focally 3

More than 60% of ARDS patients experience hemodynamic instability, which is critical to recognize as circulatory failure is the main factor associated with mortality 4
Persistent hypotension requiring vasopressors to maintain mean arterial pressure ≥65 mmHg despite adequate fluid resuscitation is a common complication 1
Elevated serum lactate levels (>2 mmol/L) indicating tissue hypoperfusion and anaerobic metabolism are often seen in ARDS patients 1
Right ventricular failure precipitated by increased pulmonary vascular resistance from lung collapse and increased afterload is a potential complication 1
Approximately 65% of patients require catecholamine infusion 4

Altered mental status ranging from confusion to coma is a common neurologic symptom 1
Decreased level of consciousness not attributable to sedation is often seen in ARDS patients 1
Delirium with either agitation or lethargy is a potential complication 1

The clinical presentation evolves through distinct phases that fundamentally alter prognosis 3
The exudative phase (1-2 days) is characterized by initial development of interstitial swelling, proteinaceous alveolar edema, hemorrhage, and hyaline membrane formation 3
The fibroproliferative phase is marked by type II alveolar cells proliferating and fibroblasts depositing collagen, indicating a critical prognostic juncture 3
The fibrotic phase (after 10-14 days) is characterized by development of pulmonary fibrosis and vascular obliteration with persistently elevated dead-space ventilation despite improving oxygenation, indicating worse outcomes 1, 3

The number of failing organ systems is the most important prognostic indicator, with mortality increasing exponentially with each additional organ failure 1
28-33% of patients with sepsis meet ARDS criteria at sepsis onset 3
Death results primarily from multiorgan failure rather than isolated respiratory failure, with overall mortality approximately 40% 1, 3
Liver failure in association with ARDS carries particularly poor prognosis and should trigger aggressive supportive measures 1, 3

The degree of initial hypoxemia is NOT a reliable prognostic indicator 1
Standard chest X-rays are poor predictors of oxygenation defect severity, clinical outcome, or fibrosis development 3
After 7-10 days, persistent high minute ventilation requirements despite improving oxygenation indicates developing fibrosis 1
Failure to recognize evolving multiorgan dysfunction, particularly hepatic and cardiovascular systems, as these determine survival more than respiratory parameters 1